InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,215.40
(
0.03%
)
US TECH 100
17,672.20
(
0.18%
)
Dow Jones
39,478.84
(
0.23%
)
Brent Oil
82.77
(
-1.41%
)
Bitcoin
60,548.20
(
-3.97%
)
Post# of 251785
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119608
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 216954

Friday, 02/23/2018 9:36:55 AM

Friday, February 23, 2018 9:36:55 AM

Post# of 251785
BLCM +9% on BPX-501 clinical-hold update:

https://finance.yahoo.com/news/bellicum-announces-clinical-hold-u-120000591.html

To address the FDA requirements, the Company plans to implement revisions to the U.S. study protocols, including the addition of more comprehensive monitoring and management of neurotoxicity. In addition, the Company will revise the Investigator Brochure and Informed Consent Documents to inform healthcare providers, patients and caregivers of the changes. The Company expects to provide a full response to the FDA within a few weeks.

The hold itself has not yet been lifted.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up